Matrix Metalloproteinase Genes Are Associated with Breast Cancer Risk and Survival: The Breast Cancer Health Disparities Study

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Slattery, Martha L ^a   John, Esther ^b,c   Torres Mejia, Gabriela ^d   Stern, Mariana ^e   Lundgreen, Abbie ^a   Hines, Lisa ^f   Giuliano, Anna ^g   Baumgartner, Kathy ^h   Herrick, Jennifer ^a   Wolff, Roger K ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^c STANFORD CANCER INSTITUTE   (United States)

^d INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f UNIVERSITY OF COLORADO   (United States)

^g H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^h UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; PROGESTERONE RECEPTOR; STROMELYSIN;

ADULT; AGED; AMERICAN INDIAN; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; CAUCASIAN; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEALTH DISPARITY; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; MMP GENE; MMP1 GENE; MMP2 GENE; MMP3 GENE; MMP9 GENE; PLESIOMORPHY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BREAST NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HISPANIC AMERICANS; HUMANS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84877809189     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063165     Document Type: Article

References (22)

1. Stamenkovic I, (2000) Matrix metalloproteinases in tumor invasion and metastasis. Seminars in cancer biology 10: 415-433.
2. Visse R, Nagase H, (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circulation research 92: 827-839.
3. Liu D, Guo H, Li Y, Xu X, Yang K, et al. (2012) Association between polymorphisms in the promoter regions of matrix metalloproteinases (MMPs) and risk of cancer metastasis: a meta-analysis. PLoS One 7: e31251.
4. McColgan P, Sharma P, (2009) Polymorphisms of matrix metalloproteinases 1, 2, 3 and 9 and susceptibility to lung, breast and colorectal cancer in over 30,000 subjects. International journal of cancer Journal international du cancer 125: 1473-1478.
5. Grieu F, Li WQ, Iacopetta B, (2004) Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype. Breast Cancer Research and Treatment 88: 197-204.
6. Beeghly-Fadiel A, Lu W, Long JR, Shu XO, Zheng Y, et al. (2009) Matrix metalloproteinase-2 polymorphisms and breast cancer susceptibility. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 18: 1770-1776.
7. Delgado-Enciso I, Cepeda-Lopez FR, Monrroy-Guizar EA, Bautista-Lam JR, Andrade-Soto M, et al. (2008) Matrix metalloproteinase-2 promoter polymorphism is associated with breast cancer in a Mexican population. Gynecologic and obstetric investigation 65: 68-72.
8. Beeghly-Fadiel A, Cai Q, Lu W, Long J, Gao YT, et al. (2009) No association between matrix metalloproteinase-1 or matrix metalloproteinase-3 polymorphisms and breast cancer susceptibility: a report from the Shanghai Breast Cancer Study. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 18: 1324-1327.
9. Siegel R, Naishadham D, Jemal A, (2012) Cancer statistics for Hispanics/Latinos, 2012. CA: a cancer journal for clinicians 62: 283-298.
10. Slattery ML, John EM, Torres-Mejia G, Lundgreen A, Herrick JS, et al. (2012) Genetic variation in genes involved in hormones, inflammation and energetic factors and breast cancer risk in an admixed population. Carcinogenesis 33: 1512-1521.
11. Slattery ML, Sweeney C, Edwards S, Herrick J, Baumgartner K, et al. (2007) Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women. Breast Cancer Res Treat 102: 85-101.
12. John EM, Horn-Ross PL, Koo J, (2003) Lifetime physical activity and breast cancer risk in a multiethnic population: the San Francisco Bay area breast cancer study. Cancer Epidemiol Biomarkers Prev 12: 1143-1152.
13. John EM, Phipps AI, Davis A, Koo J, (2005) Migration history, acculturation, and breast cancer risk in Hispanic women. Cancer Epidemiol Biomarkers Prev 14: 2905-2913.
14. Falush D, Stephens M, Pritchard JK, (2003) Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 164: 1567-1587.
15. Pritchard JK, Stephens M, Donnelly P, (2000) Inference of population structure using multilocus genotype data. Genetics 155: 945-959.
16. Nyholt DR, (2004) A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. American journal of human genetics 74: 765-769.
17. Li J, Ji L, (2005) Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 95: 221-227.
18. Yu K, Li Q, Bergen AW, Pfeiffer RM, Rosenberg PS, et al. (2009) Pathway analysis by adaptive combination of P-values. Genetic epidemiology 33: 700-709.
19. Kai Yu OL, Wheeler W (2011) ARTP Gene and Pathway p-values computed using the Adaptive Rank Truncated Product. 2.0.0 ed. pp. R package.
20. Roehe AV, Frazzon AP, Agnes G, Damin AP, Hartman AA, et al. (2007) Detection of polymorphisms in the promoters of matrix metalloproteinases 2 and 9 genes in breast cancer in South Brazil: preliminary results. Breast Cancer Research and Treatment 102: 123-124.
21. Zhou Y, Yu C, Miao X, Tan W, Liang G, et al. (2004) Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes. Carcinogenesis 25: 399-404.
22. Przybylowska K, Kluczna A, Zadrozny M, Krawczyk T, Kulig A, et al. (2006) Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer. Breast Cancer Research and Treatment 95: 65-72.